BRIACELL THERAPEUTICS CORP's ticker is BCTXW and the CUSIP is 10778Y112. A total of 9 filers reported holding BRIACELL THERAPEUTICS CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $159,022 | -56.0% | 64,907 | -46.8% | 0.03% | -71.9% |
Q1 2023 | $361,369 | -41.9% | 122,084 | -61.7% | 0.12% | -48.7% |
Q4 2022 | $621,972 | -12.4% | 318,960 | +16.6% | 0.24% | -8.5% |
Q3 2022 | $710,000 | +40.0% | 273,654 | +40.5% | 0.26% | +53.6% |
Q2 2022 | $507,000 | – | 194,817 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Privium Fund Management B.V. | 318,960 | $621,972 | 0.24% |
Murchinson Ltd. | 522,203 | $1,075,686 | 0.14% |
K.J. Harrison & Partners Inc | 208,376 | $581,382 | 0.11% |
Redmond Asset Management, LLC | 75,000 | $144,000 | 0.05% |
ARMISTICE CAPITAL, LLC | 375,000 | $772,463 | 0.01% |
ZEKE CAPITAL ADVISORS, LLC | 45,000 | $92,696 | 0.01% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
BANK OF AMERICA CORP /DE/ | 472 | $972 | 0.00% |
UBS Group AG | 1,441 | $2,968 | 0.00% |